Bright Minds Biosciences (DRUG) Enterprise Value (2020 - 2026)
Bright Minds Biosciences (DRUG) posted Enterprise Value of -$226.0 million for Q1 2026, down 253.17% on a QoQ basis from -$64.0 million in Q4 2025, and down 481.39% year-over-year from $59.2 million in Q1 2025.
Bright Minds Biosciences (DRUG) Enterprise Value (2020 - 2026) Analysis & Trends
Bright Minds Biosciences' Enterprise Value history runs 7 years deep, the most recent figure standing at -$226.0 million for Q1 2026.
- Quarterly Enterprise Value fell 481.39% year-over-year to -$226.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$226.0 million (down 481.39% YoY) and the FY2025 annual result came in at -$60.3 million, down 1316.87% from the prior year.
- Enterprise Value was -$226.0 million for Q1 2026 at Bright Minds Biosciences, down from -$64.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$4.3 million in Q3 2024 and bottomed at -$226.0 million in Q1 2026.
- A 5-year average of -$31.6 million and a median of -$8.3 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value jumped 61.92% — and 2025, when it slumped 1316.87%.
- Bright Minds Biosciences' Enterprise Value stood at -$8.3 million in 2022, then soared by 39.57% to -$5.0 million in 2023, then plunged by 725.19% to -$41.5 million in 2024, then plunged by 54.14% to -$64.0 million in 2025, then sank by 253.17% to -$226.0 million in 2026.
- Business Quant data shows DRUG's Enterprise Value at -$226.0 million in Q1 2026, -$64.0 million in Q4 2025, and -$60.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - | -225.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -225.95 Mn |
| Dec 31, 2025 | -63.98 Mn |
| Sep 30, 2025 | -60.31 Mn |
| Jun 30, 2025 | -37.15 Mn |
| Mar 31, 2025 | -38.86 Mn |
| Dec 31, 2024 | -41.51 Mn |
| Sep 30, 2024 | -4.26 Mn |
| Jun 30, 2024 | -4.59 Mn |
| Mar 31, 2024 | -4.47 Mn |
| Dec 31, 2023 | -5.03 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Jun 30, 2023 | -6.05 Mn |
| Mar 31, 2023 | -7.22 Mn |
| Dec 31, 2022 | -8.32 Mn |
| Sep 30, 2022 | -8.98 Mn |
| Jun 30, 2022 | -6.84 Mn |
| Mar 31, 2022 | -9.12 Mn |
| Dec 31, 2021 | -12.06 Mn |
| Sep 30, 2021 | -15.77 Mn |
| Jun 30, 2021 | -17.97 Mn |